Richard Mulligan is Director of Bausch Health Companies Inc.. Currently has a direct ownership of 65,909 shares of BHC, which is worth approximately $644,590. The most recent transaction as insider was on May 19, 2023, when has been sold 29,205 shares (Common Shares, no par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.9K
0% 3M change
0% 12M change
Total Value Held $644,590

Richard Mulligan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2023
BUY
Grant, award, or other acquisition
-
29,205 Added 30.71%
65,909 Common Shares, no par ...
Jun 24 2022
BUY
Grant, award, or other acquisition
-
34,387 Added 48.37%
36,704 Common Shares, no par ...
May 13 2022
BUY
Grant, award, or other acquisition
-
2,317 Added 50.0%
2,317 Common Shares, no par ...

Also insider at

BIIB
BIOGEN INC. Healthcare
SANA
Sana Biotechnology, Inc. Healthcare
RM

Richard Mulligan

Director
Bridgewater, NJ

Track Institutional and Insider Activities on BHC

Follow Bausch Health Companies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC